Chun Yu Li1, Tian Mi Yang1, Ru Wei Ou1, Qian Qian Wei1, Hui Fang Shang2. 1. Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatric, West China Hospital, Sichuan University, Chengdu, China. 2. Department of Neurology, Laboratory of Neurodegenerative Disorders, National Clinical Research Center for Geriatric, West China Hospital, Sichuan University, Chengdu, China. hfshang2002@126.com.
Abstract
BACKGROUND: Epidemiological and clinical studies have suggested comorbidity between amyotrophic lateral sclerosis (ALS) and autoimmune disorders. However, little is known about their shared genetic architecture. METHODS: To examine the relation between ALS and 10 autoimmune diseases, including asthma, celiac disease (CeD), Crohn's disease (CD), inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), and ulcerative colitis (UC), and identify shared risk loci, we first estimated the genetic correlation using summary statistics from genome-wide association studies, and then analyzed the genetic enrichment leveraging the conditional false discovery rate statistical method. RESULTS: We identified a significant positive genetic correlation between ALS and CeD, MS, RA, and SLE, as well as a significant negative genetic correlation between ALS and IBD, UC, and CD. Robust genetic enrichment was observed between ALS and CeD and MS, and moderate enrichment was found between ALS and UC and T1D. Thirteen shared genetic loci were identified, among which five were suggestively significant in another ALS GWAS, namely rs3828599 (GPX3), rs3849943 (C9orf72), rs7154847 (G2E3), rs6571361 (SCFD1), and rs9903355 (GGNBP2). By integrating cis-expression quantitative trait loci analyses in Braineac and GTEx, we further identified GGNBP2, ATXN3, and SLC9A8 as novel ALS risk genes. Functional enrichment analysis indicated that the shared risk genes were involved in four pathways including membrane trafficking, vesicle-mediated transport, ER to Golgi anterograde transport, and transport to the Golgi and subsequent modification. CONCLUSIONS: Our findings demonstrate a specific genetic correlation between ALS and autoimmune diseases and identify shared risk loci, including three novel ALS risk genes. These results provide a better understanding for the pleiotropy of ALS and have implications for future therapeutic trials.
BACKGROUND: Epidemiological and clinical studies have suggested comorbidity between amyotrophic lateral sclerosis (ALS) and autoimmune disorders. However, little is known about their shared genetic architecture. METHODS: To examine the relation between ALS and 10 autoimmune diseases, including asthma, celiac disease (CeD), Crohn's disease (CD), inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), and ulcerative colitis (UC), and identify shared risk loci, we first estimated the genetic correlation using summary statistics from genome-wide association studies, and then analyzed the genetic enrichment leveraging the conditional false discovery rate statistical method. RESULTS: We identified a significant positive genetic correlation between ALS and CeD, MS, RA, and SLE, as well as a significant negative genetic correlation between ALS and IBD, UC, and CD. Robust genetic enrichment was observed between ALS and CeD and MS, and moderate enrichment was found between ALS and UC and T1D. Thirteen shared genetic loci were identified, among which five were suggestively significant in another ALS GWAS, namely rs3828599 (GPX3), rs3849943 (C9orf72), rs7154847 (G2E3), rs6571361 (SCFD1), and rs9903355 (GGNBP2). By integrating cis-expression quantitative trait loci analyses in Braineac and GTEx, we further identified GGNBP2, ATXN3, and SLC9A8 as novel ALS risk genes. Functional enrichment analysis indicated that the shared risk genes were involved in four pathways including membrane trafficking, vesicle-mediated transport, ER to Golgi anterograde transport, and transport to the Golgi and subsequent modification. CONCLUSIONS: Our findings demonstrate a specific genetic correlation between ALS and autoimmune diseases and identify shared risk loci, including three novel ALS risk genes. These results provide a better understanding for the pleiotropy of ALS and have implications for future therapeutic trials.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Hussein Daoud; Véronique Belzil; Sandra Martins; Mike Sabbagh; Pierre Provencher; Lucette Lacomblez; Vincent Meininger; William Camu; Nicolas Dupré; Patrick A Dion; Guy A Rouleau Journal: Arch Neurol Date: 2011-06
Authors: Aree Witoelar; Iris E Jansen; Yunpeng Wang; Rahul S Desikan; J Raphael Gibbs; Cornelis Blauwendraat; Wesley K Thompson; Dena G Hernandez; Srdjan Djurovic; Andrew J Schork; Francesco Bettella; David Ellinghaus; Andre Franke; Benedicte A Lie; Linda K McEvoy; Tom H Karlsen; Suzanne Lesage; Huw R Morris; Alexis Brice; Nicholas W Wood; Peter Heutink; John Hardy; Andrew B Singleton; Anders M Dale; Thomas Gasser; Ole A Andreassen; Manu Sharma Journal: JAMA Neurol Date: 2017-07-01 Impact factor: 18.302
Authors: Beben Benyamin; Ji He; Qiongyi Zhao; Jacob Gratten; Fleur Garton; Paul J Leo; Zhijun Liu; Marie Mangelsdorf; Ammar Al-Chalabi; Lisa Anderson; Timothy J Butler; Lu Chen; Xiang-Ding Chen; Katie Cremin; Hong-Weng Deng; Matthew Devine; Janette Edson; Jennifer A Fifita; Sarah Furlong; Ying-Ying Han; Jessica Harris; Anjali K Henders; Rosalind L Jeffree; Zi-Bing Jin; Zhongshan Li; Ting Li; Mengmeng Li; Yong Lin; Xiaolu Liu; Mhairi Marshall; Emily P McCann; Bryan J Mowry; Shyuan T Ngo; Roger Pamphlett; Shu Ran; David C Reutens; Dominic B Rowe; Perminder Sachdev; Sonia Shah; Sharon Song; Li-Jun Tan; Lu Tang; Leonard H van den Berg; Wouter van Rheenen; Jan H Veldink; Robyn H Wallace; Lawrie Wheeler; Kelly L Williams; Jinyu Wu; Xin Wu; Jian Yang; Weihua Yue; Zong-Hong Zhang; Dai Zhang; Peter G Noakes; Ian P Blair; Robert D Henderson; Pamela A McCombe; Peter M Visscher; Huji Xu; Perry F Bartlett; Matthew A Brown; Naomi R Wray; Dongsheng Fan Journal: Nat Commun Date: 2017-09-20 Impact factor: 14.919
Authors: Anne E Visser; Raha Pazoki; Sara L Pulit; Wouter van Rheenen; Joost Raaphorst; Anneke J van der Kooi; Isis Ricaño-Ponce; Cisca Wijmenga; Henny G Otten; Jan H Veldink; Leonard H van den Berg Journal: J Neurol Date: 2017-02-06 Impact factor: 4.849
Authors: Martin R Turner; Raph Goldacre; Sreeram Ramagopalan; Kevin Talbot; Michael J Goldacre Journal: Neurology Date: 2013-08-14 Impact factor: 9.910
Authors: Ole A Andreassen; Wesley K Thompson; Andrew J Schork; Stephan Ripke; Morten Mattingsdal; John R Kelsoe; Kenneth S Kendler; Michael C O'Donovan; Dan Rujescu; Thomas Werge; Pamela Sklar; J Cooper Roddey; Chi-Hua Chen; Linda McEvoy; Rahul S Desikan; Srdjan Djurovic; Anders M Dale Journal: PLoS Genet Date: 2013-04-25 Impact factor: 5.917
Authors: Katrina M de Lange; Loukas Moutsianas; James C Lee; Christopher A Lamb; Yang Luo; Nicholas A Kennedy; Luke Jostins; Daniel L Rice; Javier Gutierrez-Achury; Sun-Gou Ji; Graham Heap; Elaine R Nimmo; Cathryn Edwards; Paul Henderson; Craig Mowat; Jeremy Sanderson; Jack Satsangi; Alison Simmons; David C Wilson; Mark Tremelling; Ailsa Hart; Christopher G Mathew; William G Newman; Miles Parkes; Charlie W Lees; Holm Uhlig; Chris Hawkey; Natalie J Prescott; Tariq Ahmad; John C Mansfield; Carl A Anderson; Jeffrey C Barrett Journal: Nat Genet Date: 2017-01-09 Impact factor: 41.307
Authors: Oliver J Ziff; Benjamin E Clarke; Doaa M Taha; Hamish Crerar; Nicholas M Luscombe; Rickie Patani Journal: Genome Res Date: 2021-12-28 Impact factor: 9.043